Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Peripheral effects Via the AMY2 and AMY3 receptors Cagrilintide acts peripherally: Slowing of gastric emptying , stronger than with GLP-1 Suppression of postprandial glucagon , helps control postprandial glycemic spikes Modulation of bone remodeling (via AMY3), a neutral effect, but clinically monitored Synergy with GLP-1 (the mechanistic basis of CagriSema) The main innovation is the complementarity with the GLP-1 pathway : GLP-1 suppresses appetite via the arcuate nucleus of the hypothalamus (POMC neurons, AgRP/NPY inhibition) Amylin suppresses appetite via the area postrema (CGRP-like neurons) Two independent centers, two independent mechanisms
Look for HPLC-MS testing confirming peptide identity and purity of 98% or higher, ideally 99% or above
Flagg EW, Coates RJ, Eley JW, Jones DP, Gunter EW, Byers TE et al
doi: 10.1371/journal.pone.0077268 29
Immediately after LPS injection, RBC increased significantly, accompanied by an increase in lactate, a decrease in blood pH, and an increase in respiratory rate, as published by Meyer et al
Dorward, S
